Brain Tumor Epidemiology Consortium Board of Officers
Co-Presidents:
Roberta McKean-Cowdin, Ph.D. (2024-2026), University of Southern California, Los Angeles, United States
Fabio Girardi, M.D., Ph.D. (2025-2027), Instituto Oncologico Veneto, Padova, Italy
Co-Vice-Presidents:
Stephen Francis, Ph.D. (2024-2026), University of California San Francisco, San Francisco, CA, United States
Karen Alpen, Ph.D. (2025-2027), University of Melbourne, Melbourne, Australia
Secretary:
Christine Ballard Pittman, M.P.H. (2025-2027), Duke University School of Medicine, Durham NC, United States
Treasurer:
Thanh Hoang, Ph.D. (2025-2027), Baylor College of Medicine, Texas Children’s Hospital, Houston TX, United States
Board of Directors :
Michael Scheurer, M.P.H., Ph.D., FACE, Emory University School of Medicine, Atlanta GA, United States
Karen Alpen, Ph.D., Centre for Epidemiology and Biostatistics, Melbourne School of Public & Global Health, University of Melbourne, Australia
Luc Bauchet, M.D., Ph.D., Centre Hospitalo-Universitaire (CHU) and National Institute of Health and Medical Research (INSERM), Montpellier, France
Scott Coven, M.D., Indiana University School of Medicine, Indianapolis IN, United States
Jon Foss-Skiftesvik, M.D., Ph.D., Rigshospitalet University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark
Thanh Hoang, Ph.D., Baylor College of Medicine, Texas Children’s Hospital, Houston TX, United States
Kim Johnson, M.P.H., Ph.D., Washington University in St. Louis, St. Louis, Missouri, United States
Carol Kruchko, B.A., Central Brain Tumor Registry of the United States, Hinsdale, IL
Friederike Erdmann, Ph.D., Danish Cancer Society Research Center, Copenhagen, Denmark
Maria Feychting, Ph.D., Karolinska Institute, Stockholm, Sweden
Stephen B. Francis, Ph.D., University of California San Francisco, San Francisco, United States
Johannes Hainfellner, M.D., Medical University of Vienna, Vienna, Austria
Ching Lau, M.D., Ph.D., Connecticut Children’s Medical Center, Hartford CT; Jackson Lab for Genomic Medicine and University of Connecticut School of Medicine, Farmington CT
Roberta McKean-Cowdin, Ph.D., University of Southern California, California
Christine Ballard Pittman, Ph.D., Duke University School of Medicine, Durham NC, United States
Joseph Wiemels, Ph.D., University of Southern California, Los Angeles, United States
John Villano, M.D., Ph.D, University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States
Diana Withrow, Ph.D., London School of Hygiene and Tropical Medicine, London, United Kingdom
Yan Yuan, Ph.D., University of Alberta, Edmonton, Alberta, Canada
Emeritus Board Members:
Jill Barnholtz-Sloan, Ph.D., M.S., Emory University Winship Cancer Institute, Atlanta GA, United States.
Melissa Bondy, Ph.D., Stanford Cancer Center, Stanford, California, United States
Helle Broholm, M.D., Department of Neuropathology, Rigshospitalet Copenhagen, Denmark
Adelheid Wohrer, M.D., Medical University of Vienna, Vienna, Austria
Isabelle Deltour, Ph.D., International Agency for Research on Cancer, Lyon, France
Faith Davis, Ph.D. M.P.H., School of Public Health, University of Alberta, Edmonton, Alberta, Canada
Paul Graham Fisher, M.D., Stanford University, Palo Alto, California, United States
Peter Inskip, Sc.D., Radiation Epidemiology Branch, U.S. National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Beatrice Melin, M.D., Ph.D., Oncology, Department of Radiation Sciences, University of Umea, Umea, Sweden
Sonia Partap, M.D., Stanford University, Palo Alto, California, United States
Preetha Rajaraman, Ph.D., Center for Global Health, U.S. National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States
Siegal Sadetzki, M.D., M.P.H., Cancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Aviv University, Israel
Brigitte Schlehofer, M.D., German Cancer Research Center, Heidelberg, Germany
Margaret Wrensch, Ph.D., University of California, San Francisco, United States